Clinical Trial Update: Phase III Study of CG100649 in Osteoarthritis Patients [Phase 3]

View source ↗

Summary

Phase III clinical trial of CG100649 in localized osteoarthritis of hip and knee completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Localized
• Osteoarthritis of Hip
• Osteoarthritis of Knee

Drugs mentioned

• CG100649 (CG100649)

Snippet

Sponsor: CrystalGenomics, Inc. | Conditions: Localized Primary Osteoarthritis of Hip, Localized Primary Osteoarthritis of Knee | Phase 3 | Status: COMPLETED | Results posted: 2023-02-15